{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:15:51Z","timestamp":1785773751980,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81873156"],"award-info":[{"award-number":["No. 81873156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["No. 2018YFE0195200"],"award-info":[{"award-number":["No. 2018YFE0195200"]}]},{"name":"key research and development project of Liaoning Province","award":["No.2018225054"],"award-info":[{"award-number":["No.2018225054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-025-01283-z","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:26:44Z","timestamp":1769596004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic and Diagnostic Value of Serum Bile Acid Profiles in Pancreatic Cancer: a Retrospective Multicenter Cohort Study"],"prefix":"10.1007","volume":"57","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"10242","key":"1283_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320.","journal-title":"Lancet"},{"issue":"43","key":"1283_CR2","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","volume":"24","author":"A McGuigan","year":"2018","unstructured":"McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846\u201361.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1283_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"1283_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851\u201362.","journal-title":"JAMA"},{"issue":"20","key":"1283_CR5","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1200\/JCO.2017.72.4948","volume":"35","author":"AA Khorana","year":"2017","unstructured":"Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, et al. Potentially curable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(20):2324\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1283_CR6","first-page":"188318","volume":"1873","author":"J Carmicheal","year":"2020","unstructured":"Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, et al. Elevating pancreatic cystic lesion stratification: current and future pancreatic cancer biomarker(s). Biochim Biophys Acta. 2020;1873(1):188318.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1283_CR7","first-page":"188409","volume":"1875","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, Qian Y, Huang Q, Ni Q, Liu C, et al. Roles of CA19-9 in pancreatic cancer: biomarker, predictor and promoter. Biochim Biophys Acta. 2021;1875(2):188409.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1283_CR8","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1038\/s41598-019-46634-6","volume":"9","author":"RA Gaiser","year":"2019","unstructured":"Gaiser RA, Pessia A, Ateeb Z, Davanian H, Fernandez Moro C, Alkharaan H, Healy K, Ghazi S, Arnelo U, Valente R, et al. Integrated targeted metabolomic and lipidomic analysis: a novel approach to classifying early cystic precursors to invasive pancreatic cancer. Sci Rep. 2019;9(1):10208.","journal-title":"Sci Rep"},{"issue":"8","key":"1283_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00432-011-0992-2","volume":"137","author":"JY Park","year":"2011","unstructured":"Park JY, Kim SA, Chung JW, Bang S, Park SW, Paik YK, Song SY. Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. J Cancer Res Clin Oncol. 2011;137(8):1229\u201338.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1283_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejca.2021.05.033","volume":"154","author":"HMH Diab","year":"2021","unstructured":"Diab HMH, Smith HG, Jensen KK, J\u00f8rgensen LN. The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: a systematic review. Eur J Cancer. 2021;154:73\u201381.","journal-title":"Eur J Cancer"},{"issue":"7","key":"1283_CR11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1210\/en.2019-00165","volume":"160","author":"J Fest","year":"2019","unstructured":"Fest J, Vijfhuizen LS, Goeman JJ, Veth O, Joensuu A, Perola M, M\u00e4nnist\u00f6 S, Ness-Jensen E, Hveem K, Haller T, et al. Search for early pancreatic cancer blood biomarkers in five European prospective population biobanks using metabolomics. Endocrinology. 2019;160(7):1731\u201342.","journal-title":"Endocrinology"},{"issue":"7","key":"1283_CR12","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019;156(7):2024\u201340.","journal-title":"Gastroenterology"},{"issue":"1","key":"1283_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2011.12.004","volume":"21","author":"M Quante","year":"2012","unstructured":"Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, Lee Y, Friedman R, Asfaha S, Dubeykovskaya Z, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21(1):36\u201351.","journal-title":"Cancer Cell"},{"issue":"8","key":"1283_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00204-011-0648-7","volume":"85","author":"C Bernstein","year":"2011","unstructured":"Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011;85(8):863\u201371.","journal-title":"Arch Toxicol"},{"issue":"1","key":"1283_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/1541-7786.MCR-13-0503","volume":"12","author":"E Lozano","year":"2014","unstructured":"Lozano E, Sanchez-Vicente L, Monte MJ, Herraez E, Briz O, Banales JM, Marin JJ, Macias RI. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development. Mol Cancer Res MCR. 2014;12(1):91\u2013100.","journal-title":"Mol Cancer Res MCR"},{"issue":"9","key":"1283_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbabio.2018.04.002","volume":"1859","author":"E Miko","year":"2018","unstructured":"Miko E, Vida A, Kovacs T, Ujlaki G, Trencsenyi G, Marton J, Sari Z, Kovacs P, Boratko A, Hujber Z, et al. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. Biochim Biophys Acta Bioenerg. 2018;1859(9):958\u201374.","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"1","key":"1283_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13402-017-0353-5","volume":"41","author":"TH Luu","year":"2018","unstructured":"Luu TH, Bard JM, Carbonnelle D, Chaillou C, Huvelin JM, Bobin-Dubigeon C, Nazih H. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells. Cell Oncol (Dordr). 2018;41(1):13\u201324.","journal-title":"Cell Oncol (Dordr)"},{"issue":"5","key":"1283_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/cancers12051068","volume":"12","author":"B Kiss","year":"2020","unstructured":"Kiss B, Miko E, Sebo E, Toth J, Ujlaki G, Szabo J, Uray K, Bai P, Arkosy P. Oncobiosis and microbial metabolite signaling in pancreatic adenocarcinoma. Cancers (Basel). 2020;12(5):1068.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1283_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s12010-013-0417-6","volume":"171","author":"W Song","year":"2013","unstructured":"Song W, Yang HB, Chen P, Wang SM, Zhao LP, Xu WH, Fan HF, Gu X, Chen LY. Apoptosis of human gastric carcinoma SGC-7901 induced by deoxycholic acid via the mitochondrial-dependent pathway. Appl Biochem Biotechnol. 2013;171(4):1061\u201371.","journal-title":"Appl Biochem Biotechnol"},{"issue":"Pt 2","key":"1283_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/bj3560481","volume":"356","author":"AA Powell","year":"2001","unstructured":"Powell AA, LaRue JM, Batta AK, Martinez JD. Bile acid hydrophobicity is correlated with induction of apoptosis and\/or growth arrest in HCT116 cells. Biochem J. 2001;356(Pt 2):481\u20136.","journal-title":"Biochem J"},{"issue":"5","key":"1283_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/CEJ.0b013e32834ef16f","volume":"21","author":"R Peiro-Jordan","year":"2012","unstructured":"Peiro-Jordan R, Krishna-Subramanian S, Hanski ML, Luscher-Firzlaff J, Zeitz M, Hanski C. The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression. Eur J Cancer Prev. 2012;21(5):413\u201322.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"1283_CR22","doi-asserted-by":"publisher","first-page":"G129","DOI":"10.1152\/ajpgi.00085.2014","volume":"307","author":"S Peng","year":"2014","unstructured":"Peng S, Huo X, Rezaei D, Zhang Q, Zhang X, Yu C, Asanuma K, Cheng E, Pham TH, Wang DH, et al. In Barrett\u2019s esophagus patients and Barrett\u2019s cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids. Am J Physiol Gastrointest Liver Physiol. 2014;307(2):G129-139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"42","key":"1283_CR23","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1073\/pnas.1215060109","volume":"109","author":"SM Vogel","year":"2012","unstructured":"Vogel SM, Bauer MR, Joerger AC, Wilcken R, Brandt T, Veprintsev DB, Rutherford TJ, Fersht AR, Boeckler FM. Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2. Proc Natl Acad Sci U S A. 2012;109(42):16906\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1283_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/CEJ.0000000000000198","volume":"25","author":"MM Abdel-Latif","year":"2016","unstructured":"Abdel-Latif MM, Inoue H, Reynolds JV. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells. Eur J Cancer Prev. 2016;25(5):368\u201379.","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"1283_CR25","doi-asserted-by":"publisher","first-page":"G973","DOI":"10.1152\/ajpgi.00270.2003","volume":"286","author":"G Alpini","year":"2004","unstructured":"Alpini G, Kanno N, Phinizy JL, Glaser S, Francis H, Taffetani S, LeSage G. Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol. 2004;286(6):G973-982.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"1283_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/01635581.2012.669876","volume":"64","author":"T Saeki","year":"2012","unstructured":"Saeki T, Yui S, Hirai T, Fujii T, Okada S, Kanamoto R. Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation. Nutr Cancer. 2012;64(4):617\u201326.","journal-title":"Nutr Cancer"},{"issue":"1","key":"1283_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1072-7515(99)00075-7","volume":"189","author":"SF Sener","year":"1999","unstructured":"Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985\u20131995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1\u20137.","journal-title":"J Am Coll Surg"},{"key":"1283_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jsbmb.2017.10.011","volume":"174","author":"DO Rees","year":"2017","unstructured":"Rees DO, Crick PJ, Jenkins GJ, Wang Y, Griffiths WJ, Brown TH, Al-Sarireh B. Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease. J Steroid Biochem Mol Biol. 2017;174:290\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"1283_CR29","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3748\/wjg.v9.i12.2759","volume":"9","author":"Z Wu","year":"2003","unstructured":"Wu Z, Lu Y, Wang B, Liu C, Wang ZR. Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines. World J Gastroenterol. 2003;9(12):2759\u201363.","journal-title":"World J Gastroenterol"},{"issue":"7403","key":"1283_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395\u20139.","journal-title":"Nature"},{"issue":"1","key":"1283_CR31","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1038\/s41467-024-52978-z","volume":"15","author":"V de Laat","year":"2024","unstructured":"de Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, Vanderhoydonc F, Ostyn T, Zhao P, Jacquemyn M, et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun. 2024;15(1):8540.","journal-title":"Nat Commun"},{"key":"1283_CR32","doi-asserted-by":"publisher","first-page":"725341","DOI":"10.3389\/fphar.2021.725341","volume":"12","author":"D Deng","year":"2021","unstructured":"Deng D, Pan C, Wu Z, Sun Y, Liu C, Xiang H, Yin P, Shang D. An integrated metabolomic study of osteoporosis: discovery and quantification of hyocholic acids as candidate markers. Front Pharmacol. 2021;12:725341.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1283_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1078-0432.CCR-19-1543","volume":"26","author":"JM Karasinska","year":"2020","unstructured":"Karasinska JM, Topham JT, Kalloger SE, Jang GH, Denroche RE, Culibrk L, Williamson LM, Wong HL, Lee MKC, O\u2019Kane GM, et al. Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer. Clin Cancer Res. 2020;26(1):135\u201346.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1283_CR34","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-13-2329","volume":"74","author":"NS Nagathihalli","year":"2014","unstructured":"Nagathihalli NS, Beesetty Y, Lee W, Washington MK, Chen X, Lockhart AC, Merchant NB. Novel mechanistic insights into ectodomain shedding of EGFR ligands amphiregulin and TGF-\u03b1: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res. 2014;74(7):2062\u201372.","journal-title":"Cancer Res"},{"issue":"5","key":"1283_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/13651820600804203","volume":"8","author":"JM Winter","year":"2006","unstructured":"Winter JM, Maitra A, Yeo CJ. Genetics and pathology of pancreatic cancer. HPB (Oxford). 2006;8(5):324\u201336.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"1283_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","volume":"589","author":"H Bernstein","year":"2005","unstructured":"Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589(1):47\u201365.","journal-title":"Mutat Res"},{"issue":"33","key":"1283_CR37","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.3748\/wjg.v22.i33.7463","volume":"22","author":"HY Feng","year":"2016","unstructured":"Feng HY, Chen YC. Role of bile acids in carcinogenesis of pancreatic cancer: an old topic with new perspective. World J Gastroenterol. 2016;22(33):7463\u201377.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1283_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003;83(2):633\u201371.","journal-title":"Physiol Rev"},{"key":"1283_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.physiol.64.082201.100300","volume":"64","author":"PJ Meier","year":"2002","unstructured":"Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol. 2002;64:635\u201361.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"1283_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1432-1033.1983.tb07550.x","volume":"134","author":"KM Botham","year":"1983","unstructured":"Botham KM, Boyd GS. The metabolism of chenodeoxycholic acid to beta-muricholic acid in rat liver. Eur J Biochem. 1983;134(1):191\u20136.","journal-title":"Eur J Biochem"},{"issue":"7885","key":"1283_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","volume":"599","author":"Y Sato","year":"2021","unstructured":"Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, Suda W, Takeshita K, Sasaki T, Okamoto S, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599(7885):458\u201364.","journal-title":"Nature"},{"issue":"3","key":"1283_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000371678","volume":"33","author":"JM Ridlon","year":"2015","unstructured":"Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut. Dig Dis. 2015;33(3):338\u201345.","journal-title":"Dig Dis"},{"issue":"5","key":"1283_CR43","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1128\/JB.188.5.1979-1986.2006","volume":"188","author":"P Kurdi","year":"2006","unstructured":"Kurdi P, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol. 2006;188(5):1979\u201386.","journal-title":"J Bacteriol"},{"issue":"3","key":"1283_CR44","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1080\/21655979.2022.2045823","volume":"13","author":"S Zhu","year":"2022","unstructured":"Zhu S, Yang K, Yang S, Zhang L, Xiong M, Zhang J, Chen B. A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer. Bioengineered. 2022;13(3):6719\u201328.","journal-title":"Bioengineered"},{"issue":"5","key":"1283_CR45","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","volume":"176","author":"T Fu","year":"2019","unstructured":"Fu T, Coulter S, Yoshihara E, Oh TG, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, et al. FXR regulates intestinal cancer stem cell proliferation. Cell. 2019;176(5):1098-1112.e1018.","journal-title":"Cell"},{"issue":"2","key":"1283_CR46","doi-asserted-by":"publisher","first-page":"2274124","DOI":"10.1080\/19490976.2023.2274124","volume":"15","author":"Q Wang","year":"2023","unstructured":"Wang Q, Lin H, Shen C, Zhang M, Wang X, Yuan M, Yuan M, Jia S, Cao Z, Wu C, et al. Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling. Gut Microbes. 2023;15(2):2274124.","journal-title":"Gut Microbes"},{"issue":"11","key":"1283_CR47","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1194\/jlr.M200297-JLR200","volume":"43","author":"DQ Wang","year":"2002","unstructured":"Wang DQ, Tazuma S. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L\/J mice. J Lipid Res. 2002;43(11):1960\u20138.","journal-title":"J Lipid Res"},{"issue":"2","key":"1283_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1283_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/msb4100153","volume":"3","author":"FP Martin","year":"2007","unstructured":"Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC, et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007;3:112.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"1283_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S MahmoudianDehkordi","year":"2019","unstructured":"MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, et al. Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease-An emerging role for gut microbiome. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2019;15(1):76\u201392.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"7075","key":"1283_CR51","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484\u20139.","journal-title":"Nature"},{"issue":"4","key":"1283_CR52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/cells8040293","volume":"8","author":"E Miko","year":"2019","unstructured":"Miko E, Kovacs T, Sebo E, Toth J, Csonka T, Ujlaki G, Sipos A, Szabo J, Mehes G, Bai P. Microbiome-microbial metabolome-cancer cell interactions in breast cancer-familiar, but unexplored. Cells. 2019;8(4):293.","journal-title":"Cells"},{"issue":"5","key":"1283_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","volume":"79","author":"T Re\u017een","year":"2022","unstructured":"Re\u017een T, Rozman D, Kov\u00e1cs T, Kov\u00e1cs P, Sipos A, Bai P, Mik\u00f3 E. The role of bile acids in carcinogenesis. Cell Mol Life Sci CMLS. 2022;79(5):243.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"7","key":"1283_CR54","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679-1694.e1673.","journal-title":"Gastroenterology"},{"issue":"1","key":"1283_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22\u201339.","journal-title":"Gut Microbes"},{"issue":"7","key":"1283_CR56","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cgh.2018.01.049","volume":"16","author":"SS Mukewar","year":"2018","unstructured":"Mukewar SS, Sharma A, Phillip N, Gupta R, Aryal-Khanal A, de Pretis N, Anani V, Enders FT, Larson JJ, Takahashi N, et al. Risk of pancreatic cancer in patients with pancreatic cysts and family history of pancreatic cancer. Clin Gastroenterol Hepatol. 2018;16(7):1123-1130 e1121.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"1283_CR57","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkeg\u00e5rd","year":"2017","unstructured":"Kirkeg\u00e5rd J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(9):1366\u201372.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1283_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000007755","volume":"61","author":"O Sandstad","year":"2000","unstructured":"Sandstad O, Osnes T, Skar V, Urdal P, Osnes M. Structure and composition of common bile duct stones in relation to duodenal diverticula, gastric resection, cholecystectomy and infection. Digestion. 2000;61(3):181\u20138.","journal-title":"Digestion"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01283-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01283-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01283-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:04:05Z","timestamp":1769598245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01283-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01283-z","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"13 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (approval number NCC2021C-348, Nov. 2020), the First Affiliated Hospital of Dalian Medical University (approval number PJ-KS-KY-2021\u2013203, Sep. 2021), and the ethics committee of Changhai Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}},{"value":"Z.W. and P.Y. are co-founders of iPhenome (Yun Pu Kang) biotechnology Inc.  The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"27"}}